Nasal gene therapy offers new hope for brain injury patients

This study follows 25 people aged 2 to 65 with cerebral palsy or brain damage from lack of oxygen who have already received a new gene therapy given as a nose spray. The therapy delivers 15 genes meant to repair the brain, reduce inflammation, and improve movement and thinking. Researchers will track changes in motor skills, cognition, and quality of life over a year to see if the treatment helps.